Your session is about to expire
← Back to Search
UW (perfusion solution) + sodium thiosulfate (STS) for Kidney Failure
Study Summary
This trial will determine if thiosulfate improves kidney function in recipients of deceased donor kidneys.
- Kidney Failure
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an allergy to sulfites.You recently received a kidney transplant from a living donor.
- Group 1: UW (perfusion solution) + sodium thiosulfate (STS)
- Group 2: UW (perfusion solution)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many volunteers have been recruited to participate in this experiment?
"Unfortunately, recruitment for this trial has been completed. The study was initiated on March 21st 2021 and the latest update to their database occurred October 6th 2021. If you are looking for alternatives, there are presently 586 trials recruiting participants with kidney diseases as well as 17 studies that require UW (perfusion solution) + sodium thiosulfate (STS)."
Could you elucidate any other scientific investigations conducted concerning the combination of UW and STS?
"Currently, there are 17 clinical trials in various stages of research for UW (perfusion solution) + sodium thiosulfate (STS). Three have reached Phase 3. Lismore, New South Wales is the epicentre of this research with many other locations also running related studies."
Are enrollees being accepted for this medical experiment presently?
"The information stored on clinicaltrials.gov suggests that this medical trial is not actively recruiting patients, despite having originally been posted in March 2021 and last updated in October of the same year. Nevertheless, there are 603 other trials searching for participants as of now."
Has the FDA given authorization to administer UW in conjunction with sodium thiosulfate?
"With limited data on UW (perfusion solution) + sodium thiosulfate (STS)'s safety and efficacy, this combination only scored a 1 in terms of security."
Share this study with friends
Copy Link
Messenger